Ravimtootjate Liit Ravimtootjate Liit
  • ePIL
  • APME
    • Introduction
    • APME’s mission statement, vision & objectives
    • Council
    • Members
    • Documents
    • APME events
  • ETHICS
    • APME Ethics Code
    • Ethics Committee Members
    • Breach notification
    • Joint declaration of principles of cooperation between EMA and APME
  • CONTACT US
  • English
  • Estonian
April 02, 2023May 13, 2024

Analysis “Preliminary analysis of the implementation of the electronic package leaflet (ePIL) in Estonia”

In April 2023 APME finished its analysis “Preliminary analysis of the implementation of the electronic package leaflet (ePIL) in Estonia”

The aim of the project was to carry out a preliminary analysis of the implementation of the electronic packaging information leaflet (ePIL) in Estonia, which consisted of the following activities: 1) mapping of the field in Europe – what models are used in different countries and what are the most important ongoing projects; 2) possible technical solutions – both based on the Estonian Medicines Register and the planned solution of the European Medicines Agency (EMA); 3) overview of legislation and standards; 4) mapping of expectations and needs of Estonian shareholders; 5) creation of a vision of a possible user-friendly visual solution.

The project was initiated by The Association of Pharmaceutical Manufacturers in Estonia as a country
engagement project funded by EFPIA.

More about the ePIL analysis can be read here.

LINKS

  • APME
  • APME POSITIONS
  • APME ETHICAL CODE
  • CONTACT US
  • EFPIA
  • EFPIA

ADDRESS

Hobujaama 4Tallinn10151 Estonia
MTÜ Ravimitootjate Liithttps://rtl.ee/info@rtl.ee
MTÜ Ravimitootjate Liit